The Bullfrog AI Platform
AI and ML are fully leveraged only when their outputs are reproducible, actionable, and defensible.
Through three complementary capabilities, we deliver data harmonization with human oversight, network discovery that goes beyond correlation, and traceable audit-ready risk rankings for pipeline decisions for our pharma and biotech partners.
Products
You spoke, and we listened. Each stand-alone platform addresses a current industry bottleneck.
Organizations hold vast amounts of clinical and laboratory data that tend to be fragmented, siloed, poorly annotated, and unstructured. bfPREP™ provides AI-guided data harmonization without losing biological context or human oversight.
In drug discovery or early- and mid-stage clinical pipelines, many fail due to insufficient understanding of druggable molecular driver networks or insufficiently targeted clinical trial subgrouping. bfLEAP® provides a targeted analytical approach using proprietary algorithms the surpasses broad inference and bulk-analysis methods.
If you ever sat in a committee trying to decide how to rank the projects and assets in your pipeline, you see the value of a neutral voice. bfARENAS” replaces biased, weighted scoring with structured arenas and stability scores for ranking based on your organizations identified criteria, with a complete audit trail.
In drug discovery or early- and mid-stage clinical pipelines, many fail due to insufficient understanding of druggable molecular driver networks or insufficiently targeted clinical trial subgrouping. bfLEAP® provides a targeted analytical approach using proprietary algorithms the surpasses broad inference and bulk-analysis methods.
A causal machine-learning workflow that keeps the scientist in the driver’s seat to review newly surfaced signals and meaningful networks, including subgroups and their corresponding biological asset, stability metrics assessing reproducibility, and the molecular pathway and disease evidence compiled that strengthen its significance.
A decision-maker’s tool for head-to-head assessment of your team’s criteria and priorities that provide structure and neutrality to help organizations make better informed decisions.
General-purpose AI can fall short. Our AI-enabled tech stack is optimized for reproducible, auditable, and scientifically-grounded decisions that improve process efficiency without minimizing the value of human input.
Relies on broad inference across complex datasets, reducing reliability and confidence in insights
Struggles with poorly structured, incomplete, or heterogeneous biomedical data
Outputs can change when analyses are re-run
Lacks structured scientific review and validation workflows that simplify human approval
Generates unexplainable, black-boxed, and potentially inaccurate rankings that are difficult to explain, audit, or defend
Transforms complex biomedical data into analysis-ready, audit-ready datasets with bfPREP™
Incorporates stability-validated analytics to identify reproducible causal analysis of subgroups, patterns, and networks with bfLEAP®
Produces structured, auditable decision frameworks to rank with bfARENAS™
Keeps scientists in the loop with traceable evidence, logged decisions, and human validation at each critical decision step with all three
Partner: Top 5 Global Pharmaceutical
